Price
1,504.4
+0.4%52W Range
Market Cap
₹15,479.78 Cr
Traded: ₹14.55 Cr (0.09%) 0.0x
Free Float: ₹653.25 Cr (2.23% of FF traded)
Volume · 60D trend
97.32 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +17.0% | +21.0% | -- | +20.0% | Stable |
| ROE | -- | +20.0% | +19.0% | -- | -- | Decelerating |
| Return | -- | -- | +43.0% | +29.0% | -- | Decelerating |
| Profit | -- | +15.0% | +27.0% | -- | +24.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 231 | 219 | 205 | 202 | 188 | 173 | 169 | 183 | 156 | 155 | 133 | 139 | 121 | 121 | 113 | 121 |
| Expenses | 132 | 124 | 119 | 120 | 115 | 104 | 102 | 107 | 95 | 92 | 80 | 82 | 73 | 72 | 69 | 72 |
| Operating Profit | 99 | 96 | 86 | 82 | 74 | 69 | 67 | 76 | 61 | 63 | 52 | 57 | 48 | 49 | 44 | 49 |
| OPM % | 43.0% | 44.0% | 42.0% | 41.0% | 39.0% | 40.0% | 40.0% | 42.0% | 39.0% | 41.0% | 39.0% | 41.0% | 40.0% | 41.0% | 39.0% | 40.0% |
| Other Income | 9 | 2 | 5 | 6 | 7 | 5 | 5 | 5 | 4 | 3 | 3 | 7 | 6 | 5 | 4 | 3 |
| Interest | 11 | 9 | 9 | 8 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 |
| Depreciation | 25 | 24 | 24 | 22 | 21 | 19 | 18 | 17 | 17 | 16 | 15 | 14 | 12 | 11 | 20 | 16 |
| Profit Before Tax | 71 | 64 | 58 | 58 | 52 | 47 | 47 | 57 | 42 | 44 | 35 | 45 | 35 | 36 | 22 | 31 |
| Tax % | 25.0% | 25.0% | 26.0% | 25.0% | 26.0% | 26.0% | 24.0% | 26.0% | 25.0% | 23.0% | 25.0% | 25.0% | 26.0% | 24.0% | 25.0% | 25.0% |
| Net Profit | 53 | 48 | 43 | 43 | 39 | 35 | 35 | 42 | 32 | 34 | 26 | 34 | 26 | 28 | 16 | 23 |
| Exceptional Items | -- | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 5.2 | 4.7 | 4.2 | 4.2 | 3.8 | 3.4 | 3.4 | 4.1 | 3.1 | 3.3 | 2.5 | 3.3 | 2.6 | 2.7 | 1.6 | 2.3 |
| Sales Growth (YoY) | 22.9% | 26.6% | 21.3% | 10.4% | 20.5% | 11.6% | 27.1% | 31.6% | 28.9% | 28.1% | 17.7% | 14.9% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 5.5% | 6.8% | 1.5% | 7.5% | 8.7% | 2.4% | -7.7% | 17.3% | 0.7% | 16.5% | -4.3% | 14.9% | 0.0% | 7.1% | -6.6% | -- |
| OP Growth (YoY) | 33.8% | 39.1% | 28.4% | 7.9% | 21.3% | 9.5% | 28.8% | 33.3% | 27.1% | 28.6% | 18.2% | 16.3% | -- | -- | -- | -- |
| OP Growth (QoQ) | 3.1% | 11.6% | 4.9% | 10.8% | 7.2% | 3.0% | -11.8% | 24.6% | -3.2% | 21.2% | -8.8% | 18.8% | -2.0% | 11.4% | -10.2% | -- |
| Profit Growth (YoY) | -- | 34.6% | 22.8% | 2.8% | 23.1% | 6.5% | 28.6% | 26.4% | 19.7% | 21.7% | 67.2% | 42.8% | 50.1% | 15.9% | -35.3% | -15.8% |
| EPS Growth (YoY) | 37.2% | 37.1% | 22.4% | 2.7% | 22.9% | 4.0% | 35.6% | 25.8% | 19.1% | 21.6% | 58.1% | 42.4% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 10.7% | 10.9% | -0.2% | 12.0% | 10.6% | -0.9% | -16.3% | 34.0% | -6.4% | 29.3% | -22.4% | 26.9% | -4.5% | 68.1% | -30.1% | -- |
| OP Margin | 42.9% | 43.8% | 42.0% | 40.6% | 39.4% | 39.9% | 39.6% | 41.5% | 39.1% | 40.6% | 39.1% | 41.0% | 39.7% | 40.5% | 38.9% | 40.5% |
| Net Margin | 22.9% | 21.9% | 21.0% | 21.3% | 20.7% | 20.2% | 20.7% | 22.9% | 20.5% | 21.9% | 19.6% | 24.5% | 21.5% | 23.1% | 14.2% | 19.0% |
| Material Cost % | -- | 11.4% | 11.7% | 12.1% | 11.4% | 12.8% | 12.3% | 12.6% | 12.0% | 12.1% | 12.1% | 11.8% | 11.8% | 12.8% | 12.1% | 13.8% |
| Employee Cost % | -- | 15.4% | 16.1% | 16.0% | 16.8% | 16.4% | 16.9% | 15.2% | 17.5% | 15.8% | 17.4% | 15.7% | 17.2% | 16.1% | 17.4% | 16.4% |
| P/S | 18.06 | 17.32 | 16.19 | 14.10 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 82.52 | 81.39 | 77.69 | 67.96 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 16.18 | 14.73 | 14.37 | 11.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Cessation of Dr. Manjula Anagani as Independent Director due to completion of tenure w.e.f closing of business hours on 21.08.2026
Cessation of Dr. Manjula Anagani as Independent Director on completion of tenure w.e.f 21.08.2026
Scrutinizer report for Postal Ballot
Outcome of Postal Ballot
Information relating to 24th Annual general meeting, cut-off date for remote e-voting and e-voting at AGM
Paper adv for pre-dispatch of AGM notice
Earnings call Transcript for Q1 Fy 27 held on August 07, 2026
Copy of News paper publication for Q1 results
Audit Committee and Independent Director report certifying the distribution of proceeds to shareholders of Medinova Diagnostic services Limited pursuant to scheme of Amalgamation
earnings call for Q1 FY 2026-27
Un-audited financial results for the quarter ended June 30, 2026 on consolidated & Standalone basis
Press Release on Un-audited financial results for the quarter ended June 30, 2026
Press Release on Q1 Un-audited financial results for FY 27
Investor Presentation on Un-audited results for the Quarter ended June 30, 2026
The Board of Directors in their meeting held on August 6, 2026 have approved the financial results for the quarter ended June 30, 2026
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund
Allotment of 100,987 equity shares of Rs.1/- each pursuant to exercise of options under VDCL Employee Stock Option plan 2018
Notice of Postal Ballot dated July 16, 2026
Certificate under Re 74(5) of SEBI(DP) Regulations, 2018
Appointment of Mr. Narasimha Raju as Chief Financial officer of the Company w.e.f. 09.07.2026
Appointment of Mr. Narasimha Raju as Chief financial officer of the Company w.e.f. 09.07.2026
Grant of 90,000 ESOPs under VDCL Employee Stock Option Plan 2018
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for abrdn Asia Ltd
The trading window for dealing in securities of the Company will be closed w.e.f 1st July 2026 for all the DP & their relatives and shall re-open after 48 hours after the announcement of ....
Resignation of Mr. Sai Siva Prasad as Chief Technology Officer (CTO) of the Company.
Resignation of Mr. Ankit Shah as Chief Financial Officer of the Company
As per the attachment
Appointment of Company Secretary & Compliance Officer with effect from June 01, 2026
Annual Secretarial Compliance Report for the period ended March 31, 2026
Cessation of Independent Directors upon completion of their tenure
Cessation of Independent Directors upon completion of their tenure
Appointment of Independent Directors
Earnings Call Transcript for call held on May 08, 2026
Pls refer the attachment
Scrutinizer Report on the Postal Ballot
Voting Results and Scrutinizer Report on Postal Ballot
Newspaper Advertisement Of Audited Financial Results Of The Quarter and Year Ended March 31, 2026
Audio recording of Earnings Call for Q-4 FY 2026.
Please refer the attachment
Pls refer the attachment
Pls Refer the Attachment
Pls refer the attachment
Pls refer the attachment
Pls refer the attachment
Pls refer the attachment
Pls refer the attachment
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and approve The Audited Financial ....
Earnings Call for Audited financial results for the quarter and year ended March 31, 2026.
Post Dispatch Newspaper Advt. of Postal Ballot Notice
Postal Ballot Notice for Seeking Members Approval
Credit Ratings
6Concalls
20Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Dec 2023
31 Dec 2023Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jun 2022
30 Jun 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Held by ETFs
14 ETFs hold VIJAYA · sorted by weight
Held by Mutual Funds
59 schemes hold VIJAYA · sorted by weight